ISG Begins Study, Shares Edge Up
Information Services Group (NASDAQ: III), a leading global technology research and advisory firm, has launched a research study examining providers of engineering, design, logistics and other services supporting the aerospace and defense industry.The study results will be published in two comprehensive ISG Provider Lens™ reports, called Aerospace and Defense Solutions and Services, scheduled to be released in June 2025. The reports, focused on the U.S. and European markets, respectively, will cover services offered to aircraft, spacecraft and defense systems manufacturers on both the commercial and military sides of the industry.Enterprise buyers will be able to use information from the reports to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.Ongoing geopolitical tensions coupled with new and emerging global flashpoints have elevated the need for continuous investments in countries’ defense capabilities to ensure their preparedness against potential conflicts. Countries invest heavily in modernizing their military forces, driving demand for innovative aerospace and defense solutions.Such innovations include autonomous systems, AI and advanced materials, for boosting operational efficiency and safety in commercial, business and military aviation. For instance, the adoption of drones and unmanned vehicles is revolutionizing civilian operations and combat strategies.III shares captured three cents to $3.25.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


